PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 857.00
-17.00 (-1.95%)
At close: Jul 22, 2026
PeopleBio Market Cap
PeopleBio has a market cap or net worth of 21.21 billion as of July 21, 2026. Its market cap has decreased by -61.55% in one year.
Market Cap
21.21B
Enterprise Value
31.62B
Revenue
2.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
857.00
ChartMarket Cap Chart
Since October 19, 2020, PeopleBio's market cap has decreased from 127.63B to 21.21B, a decrease of -83.39%. That is a compound annual growth rate of -26.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 21.21B | -6.30% |
| Dec 30, 2025 | 22.63B | -64.95% |
| Dec 30, 2024 | 64.57B | -0.15% |
| Dec 28, 2023 | 64.67B | -65.14% |
| Dec 29, 2022 | 185.49B | 1.48% |
| Dec 30, 2021 | 182.78B | -36.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 187.75B |
| GENINUS | 89.62B |
| Cytogen | 70.36B |
| Inventera | 60.33B |
| Protia | 60.28B |
| GC Medical Science | 59.79B |
| HLB Panagene | 54.95B |
| Seoulin Bioscience | 40.05B |